Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Toho Holdings Co., Ltd. ( (JP:8129) ) has shared an announcement.
Toho Holdings has set a slate of director candidates for approval at its June 26, 2026 shareholders meeting and has provisionally chosen a new CEO, following recommendations from its Nomination and Compensation Committee, which is dominated by independent outside directors. The Audit and Supervisory Committee has already endorsed both the director nominees and the rationale for their selection, underscoring an emphasis on governance, objectivity and transparency in top management appointments.
The company tied these leadership decisions directly to its new 2026–2028 medium-term management plan, which targets a discontinuous increase in operating profit through strengthened pharmaceutical wholesale margins, efficiency gains in dispensing pharmacies, expansion of CDMO operations and diversification via medical DX and M&A. By selecting directors and a CEO against newly formalized criteria and after extensive external assessment and interviews, Toho aims to secure leadership capable of achieving its fiscal 2029 goals of at least ¥30 billion in operating profit, a 1.5% operating margin and ROE of 8%, potentially reshaping its growth trajectory and risk profile for shareholders and other stakeholders.
The most recent analyst rating on (JP:8129) stock is a Hold with a Yen5000.00 price target. To see the full list of analyst forecasts on Toho Holdings Co., Ltd. stock, see the JP:8129 Stock Forecast page.
More about Toho Holdings Co., Ltd.
Toho Holdings Co., Ltd. is a Japan-based healthcare group listed on the Tokyo Stock Exchange Prime Market, operating mainly in pharmaceutical wholesaling, dispensing pharmacy services and contract development and manufacturing (CDMO). The company is focused on boosting profitability in its core drug distribution and pharmacy businesses while expanding into new modalities, digital healthcare and allied medical domains through alliances and M&A.
Average Trading Volume: 151,926
Technical Sentiment Signal: Hold
Current Market Cap: Yen284.6B
Find detailed analytics on 8129 stock on TipRanks’ Stock Analysis page.